Menü
Dieses Wertpapier wird aktuell nicht bei uns gehandelt
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

Roche Holding AG ADR

WKN: 891106 / Symbol: RHHBY / Name: Roche / Aktie / Pharmazeutika / Large Cap /

43,85 €
-0,82 %

Roche Bobois S.a.

WKN: A2JQRU / Name: Roche Bobois S.a. / Aktie / ? /

24,60 €
-4,28 %

Roche Holding AG

WKN: A4124Y / Name: Roche Holding / Aktie / ? /

15,30 €
-3,77 %

Roche Holding AG

WKN: A40CGQ / Name: Roche Holding / Aktie / ? /

7,10 €
-3,40 %

Roche Finance Europe B.v.

WKN: A3LEL7 / Name: Roche Finance Europe B.v. / Aktie / ? /

102,31 €
0,07 %

Roche Finance Europe B.v.

WKN: A3LEL8 / Name: Roche Finance Europe B.v. / Aktie / ? /

101,78 €
0,07 %

Roche Finance Europe B.v.

WKN: A3LRTS / Name: Roche Finance Europe B.v. / Aktie / ? /

101,67 €
0,00 %

Roche Finance Europe B.v.

WKN: A3LRTT / Name: Roche Finance Europe B.v. / Aktie / ? /

101,66 €
0,16 %

Roche Finance Europe B.v.

WKN: A3LX6K / Name: Roche Finance Europe B.v. / Aktie / ? /

102,62 €
0,03 %

Roche Finance Europe B.v.

WKN: A3LX6L / Name: Roche Finance Europe B.v. / Aktie / ? /

95,64 €
0,16 %

Roche Holdings Inc.

WKN: A3LVX8 / Name: Roche Holdings Inc. / Aktie / ? /

97,84 €
0,51 %

Roche Holding AG

WKN: A424UK / Name: Roche Holding / Aktie / ? /

349,77 €
-1,42 %

Trading Roche Holding AG

Trading Roche Holding AG

FDA Grants Priority Review to Roche's Early-Stage Breast Cancer NDA
FDA Grants Priority Review to Roche's Early-Stage Breast Cancer NDA

Roche RHHBY announced that the FDA has accepted its new drug application (NDA) for its investigational candidate, giredestrant, as an adjuvant treatment for adults with oestrogen receptor

Roche Holding (RHHBY) Upgraded to Buy: Here's What You Should Know
Roche Holding (RHHBY) Upgraded to Buy: Here's What You Should Know

Investors might want to bet on Roche Holding AG (RHHBY), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is

Roche, Nurix Team Up to Advance BTK Degrader Bexobrutideg
Roche, Nurix Team Up to Advance BTK Degrader Bexobrutideg

Roche RHHBY has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics NRIX to co-develop and co-commercialize bexobrutideg (NX-5948) across malignant hematology

Rochefocauld
Account aktiviert

BAYRY or RHHBY: Which Is the Better Value Stock Right Now?
BAYRY or RHHBY: Which Is the Better Value Stock Right Now?

Investors with an interest in Large Cap Pharmaceuticals stocks have likely encountered both Bayer Aktiengesellschaft (BAYRY) and Roche Holding AG (RHHBY). But which of these two stocks presents

Top Stock Reports for Amazon, Bank of America & Roche
Top Stock Reports for Amazon, Bank of America & Roche

Monday, June 8, 2026The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amazon.com,